miR-548k regulates CXCL13 expression in myasthenia gravis patients with thymic hyperplasia and in Jurkat cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-548k regulates CXCL13 expression in myasthenia gravis patients with thymic hyperplasia and in Jurkat cells

Published:2018-07 Issue: Volume:320 Page:125-132
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Li Jinpin,Qiu Di,Chen Zezhi,Du Weiwei,Liu Jingli,Mo Xuean

Funder

Guangxi Natural Science Foundation

Guangxi Committee of Science and Technology

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference33 articles.

1. Transactivation of the estrogen receptor promoter by BRCA1;Archey;Cancer Cell Int.,2017

2. The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases;Aust;Eur. J. Endocrinol.,2004

3. MicroRNAs: genomics, biogenesis, mechanism, and function;Bartel;Cell,2004

4. The thymus in myasthenia gravis: site of "innate autoimmunity";Cavalcante;Muscle Nerve,2011

5. Autoimmune mechanisms in myasthenia gravis;Cavalcante;Curr. Opin. Neurol.,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The intricate dance of non-coding RNAs in myasthenia gravis pathogenesis and treatment;Frontiers in Immunology;2024-03-27

2. Hsa-miR-548k blocks the drug resistance cascade in NSCLC cancer by targeting the key genes involved in various chemotherapy resistance pathways;Human Gene;2024-02

3. Evaluation of altered miRNA expression pattern to predict COVID-19 severity;Heliyon;2023-02

4. miRNAs as the important regulators of myasthenia gravis: involvement of major cytokines and immune cells;Immunologic Research;2022-11-17

5. Genome-wide association study for systemic lupus erythematosus in an egyptian population;Frontiers in Genetics;2022-10-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3